Neumora Therapeutics, Inc. Presents Corporate Presentation at J.P. Morgan Healthcare Conference

Neumora Therapeutics, Inc., a Delaware-based company listed on the Nasdaq Global Select Market under the ticker symbol “NMRA,” recently disclosed its latest developments in a Form 8-K filing with the Securities and Exchange Commission (SEC) on January 13, 2025. The company shared details about its participation in the 43rd Annual J.P. Morgan Healthcare Conference, where […]

Leave a Reply

Your email address will not be published.

Previous post Critical Contrast: Privia Health Group (NASDAQ:PRVA) & Vsee Health (NASDAQ:VSEE)
Next post AutoZone, Inc. (NYSE:AZO) Sees Significant Growth in Short Interest